Outcomes from treating orthopedic infection with debridement and implanted antibiotic were similar whether followed by short or standard duration of systemic antibiotic.
|Articles|May 17, 2019
UPMC Forms Telemedicine Company to Address Infectious Disease Specialist Shortage
Author(s)Samara Rosenfeld
With a shortage in specialists, the service could help address an issue that costs health care billions of dollars a year.
Advertisement
University of Pittsburgh Medical Center has formed a telemedicine-enabled company, Infectious Disease Connect, to help hospitals address the shortage of infectious disease specialists.
The company aims to improve outcomes, reduce transfers and keep patients in their own communities for treatment.
“As diagnosing and treating infectious diseases and ‘superbugs’ become increasingly complex, having access to infectious disease experts will be essential for every healthcare facility,” said David Zynn, president of Infectious Disease Connect.
UPMC’s health system has provided infectious disease telemedicine services to patients for the past five years. Infectious Disease Connect jumps off that model, bringing a team of specialists to hospitals in a more cost-effective manner and providing primary expertise, backfill support and staff augmentation.
Health care-associated infections affect between 5 and 10% of patients and result in more than $40 billion annually in hospital costs. But with the shortage of specialists, many hospitals and smaller facilities are struggling to address these issues.
Through such telemedicine services, UPMC said it has seen a reduction in patient transfers to tertiary facilities, a reduction in healthcare-associated infections, improved patient outcomes and a reduction of antibiotic misuse.
“With the growing threat of drug-resistant organisms and costly government penalties for healthcare-associated infections, it has never been more critical for hospitals to properly diagnose, treat and prevent such infections,” said Rima Abdel-Massih, M.D., chief medical officer for Infectious Disease Connect.
Infectious Disease Connect serves 10 UPMC and five non-UPMC hospitals in Pennsylvania and surrounding states.
The company is staffed by UPMC infectious disease physicians to serve the health system. As it expands into new markets, Infectious Disease Connect plans to hire additional physicians to provide patient consultations.
In addition to the newly launched company, UPMC offers
This article, "
Advertisement
Related to this article
Investigators accessed longitudinal human data from ebola virus vaccination for signals of efficacy against the Bundibugyo species now surging in the Democratic Republic of Congo.
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Advertisement
Advertisement
Trending on Contagion Live
1
How The Food Safety Surveillance Infrastructure Works in the US
2
Evaluating Ebola Vaccine Against Current Bundibugyo Species
3
Ebola and the Ongoing Tale of US Failures
4
Implanted Antibiotic Reduced Systemic Regimen for Orthopedic Infection
5